Search Results
Results found for "Inversago Pharma"
- How GPCR Spatial Signaling Sparked a Scientific Journey
From Cambridge to Leadership That early curiosity led her to pursue a PhD in Molecular Pharmacology at 2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute of Pharmaceutical
- From Failed Experiments to Predictive GPCR Models
With limited structural data but a growing pharmacological interest, GPCRs presented the perfect challenge Collaborating with chemists, biologists, and pharmacologists not only made his predictions more useful Pharmacology, on the other hand, is often outsourced through collaborations with expert labs who specialize Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists Trainees must learn how to interpret assay data, understand pharmacological context, and communicate
- New Tools, Smart Signals, and The Kenakin Brief
Early Access and Updates Terry’s Corner is launching soon with monthly courses, AMAs, and real-world pharmacology
- The Truth About GPCR Product Launches: Years in the Making
GPCR internalization isn’t just a trafficking readout—it’s pharmacology. s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier (GPCR pharmacology
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Allosteric GPCR Binding Sites and Their Ligandability Potential Today, we started the Principles of Pharmacology News UNC School of Medicine to Receive $3-Million Award from ARPA-H’s Sprint for Women’s Health Nxera Pharma Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and I Cell Biology - Tectonic Therapeutic PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group
- Why Opposing Processes Matter for Your Next GPCR Drug
β-receptor partial agonists, showing how heart rate set-points under different anesthetics can flip observed pharmacology Subscribe today and get direct access to decades of pharmacology experience that turn complex systems Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots.
- The Five Traps of Ignoring Kinetics
That’s not pharmacology. That’s kinetics. It’s a shift in how expert drug hunters see pharmacology. Unlock “Kinetics: Advanced Applications” Only in Terry’s Corner Why Terry’s Corner Most pharmacology engagement opportunities through AMAs and topic suggestions Practical insights distilled from decades of pharmacology
- Curve Shifts Don’t Lie, But Your Eyes Might
When Curves Shift Some of the most difficult calls in pharmacology happen when two curves look slightly Is it a real pharmacological effect, or just noise? Here’s where the F-test becomes indispensable. engagement opportunities through AMAs and topic suggestions Practical insights distilled from decades of pharmacology curvecomparison #ftest #assayvalidation #experimentaldesignstatistics #assayreproducibility #ANCOVA #pharmacology
- Understanding the Journey: Catherine Demery's Path to Addiction Science
She entered undergrad set on becoming a pharmacist. After excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it kind of had an identity crisis because I think I realized in that moment that I didn't want to be a pharmacist It’s rigorous pharmacology, but deeply tied to urgent public health needs. Catherine's decision to defer pharmacy school was a leap of faith that opened new doors.
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
The turning point came during her master’s program in pharmacogenomics. Rather than treating opioid pharmacology as a purely theoretical exercise, she collaborates with harm-reduction This approach makes her models not just rigorous, but translational—bridging the gap between receptor pharmacology That personal loss transforms complex receptor pharmacology into something immediate and human. And GPCR pharmacology isn’t just an academic pursuit—it’s essential to understanding and responding to
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
First responders describe revivals that don’t feel like revivals, as if the body is still trapped in a pharmacological
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
This interest has been driving efforts to understand their pharmacology since the 1980s. CELT-335 was successfully used in assays to determine the pharmacological properties of Δ9-tetrahydrocannabinol binding of naturally occurring Δ9-tetrahydrocannabinolderivatives to cannabinoid CB1 and CB2 receptors, Pharmacological Zagzoog A et al ., In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors, British Journal of Pharmacology
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Acta Pharmacol Sin 2019 , 40 (3), 324–335. https://doi.org/10.1038/s41401-018-0164-x . (8) J Pharmacol Exp Ther 1996 , 278 (3), 989–999. (12) Martín-Fontecha, M.; Angelina, A.; Rückert Pharmacological Evaluation of New Constituents of “Spice”: Synthetic Cannabinoids Based on Indole, Indazole 1,4-Dihydroquinoline-3-Carboxamide Derivatives as New CB2 Cannabinoid Receptors Agonists: Synthesis, Pharmacological
- Radioligands vs. Fluorescent Ligands: Binding Assays
Strategic placement of the linker in the pharmacophore and its optimization ensure access to the binding site with minimal unspecific interactions, while also tuning the pharmacological, physicochemical and Radioligands have superior precision when accounting for ligand-receptor interactions, particularly in pharmacokinetic Br J Pharmacol. 2020 Mar;177(5):978-991. doi: 10.1111/bph.14953. Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
), and PL-384 (pharmacophore + linker of CELT-419), were also determined to understand any effects the For example, a Cy5-labelled fluorescent ligand with the same pharmacophore is available from Celtarys Pharmacology & Therapeutics 2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007 European Journal of Pharmacology 2017 , 799 , 58–66. https://doi.org/10.1016/j.ejphar.2017.01.040 . European Journal of Pharmacology 2018 , 839 , 40–46. https://doi.org/10.1016/j.ejphar.2018.09.008 .
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Kenakin’s latest lecture delivers a paradigm shift for pharmacologists working on drugs where in vitro Drugs with poor pharmacokinetics can outperform flashier compounds by exploiting kinetic environments future topics Access to the study group Whether you’re in hit-to-lead, lead optimization, or clinical pharmacology #PKPDdissociation #ReceptorPharmacology #InVivoPharmacology #KineticPharmacology #LeadOptimization #Pharmacokinetics #Pharmacodynamics #TissueDiffusion #DrugRebinding #ResidenceTimeMatters
- Breaking the Myth of High and Low Affinity Sites
Yet some assumptions still shaping pharmacology workflows haven’t evolved as fast as today’s science. Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
research position in GPCR biochemistry and biophysics and a research associate/scientist in in vitro pharmacology “The best pharmacology teacher (Dr. Also super-valuable for those of us learning how to teach pharmacology” — Dr. GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who
- What If Your Data is Lying to You? The Calcium Assay Dilemma
Because when true pharmacological profiling is essential—like detecting partial or inverse agonism—calcium If you're starting out in pharmacology, this lesson gives you the interpretive tools to ask smarter questions calcium assays with strategic clarity. 📍 Foundational Level | Calcium Assays 📚 Part of Terry Kenakin’s Pharmacology
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Hello GPCR Minds, This week, you'll learn all about Terry’s Pharmacology Corner, your new learning space focused on GPCR pharmacology. GPCR Updates Learn Pharmacology That Drives Discovery – From Dr. Terry Kenakin Terry’s Corner is your space focused on GPCR pharmacology designed just for you.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
See the true pharmacology: Lower sensitivity to uncover partial agonism and compare relative efficacy your topic suggestions Weekly new releases to stay ahead of the science Content built for biotech, pharma classified industry updates, priority event alerts, vetted jobs, and commentary that connects dots across pharmacology GPCR scientists, translational pharmacologists, discovery teams, and decision-makers who need fast, curated
- 📰 GPCR Weekly News, October 9 to 15, 2023
drugs hunt Sosei Heptares’ President & CEO Chris Cargill Wins Executive of the Year at the Citeline Pharma Chemotactic Cytokines GPCR Jobs NEW Head of Human Resource Business Partners Senior Scientist, In vitro pharmacology - Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist/Molecular Pharmacologist Senior Vice President
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
One of its first pillars, Terry’s Pharmacology Corner , led by Dr. Through Terry’s Pharmacology Corner , he shares decades of expertise in an accessible, on-demand format for scientists across academia, biotech, and pharma. Terry Kenakin , a pioneer who helped shape modern pharmacology and deepen our understanding of GPCR function Related Links 🔗 Explore Terry’s Pharmacology Corner → TerryKenakin.com 📧 Connect with us → Hello@
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological ASCEPT is the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology Established in 1966, ASCEPT is affiliated with the International Union of Basic and Clinical Pharmacology
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Kenakin and Hoare on ' Applying Pharmacology to Drug Discovery ' and ' Advanced Data Analysis for GPCR Pharmacology .' Dates: September 5 to 26, 2024 What You’ll Learn during the four sessions: How to measure pharmacologic for their work on GPCR pharmacogenomics Let’s dive into the Classified GPCR News from August 5th nanobodies on GPCR structural biology and their potential as therapeutic agents Industry News Nxera Pharma
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
🚨 Hurry to reserve your spot for the Principles of Pharmacology I & II BUNDLE before the Early Every Thursday at 10 AM EST: Principles of Pharmacology I Dates: October 3, 10, 17, 24 (four sessions ) Topics: Pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies. Registration deadline: September 27, 2024 Principles of Pharmacology II Dates: October 31, November 𝗦𝘂𝗺𝗺𝗮𝗿𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗼𝗳 𝗔𝗘𝗙𝟬𝟭𝟭𝟳 𝗣𝗵𝗮𝘀𝗲 𝟮𝗯 𝗶𝗻 𝗖𝗨𝗗 Nxera Pharma
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
In this lesson, you'll gain: ✅ Clarity on what “irreversible” really means in kinetic and pharmacologic Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full Here , you’ll get: Weekly lectures that sharpen your command of how enzyme activity drives pharmacokinetics
- 📰 GPCR Weekly News, June 24 to 30, 2024
hormone recognition and distinctive Gq protein coupling by the kisspeptin receptor Industry News Nxera Pharma , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Scientist; Biochemistry, Cellular and Mechanistic Pharmacology; Lead Discovery and Director GPCR Drug Discovery Biologist HIGHLIGHT Principal Scientist, In vitro pharmacology Post-Doctoral Scientist- Molecular Pharmacology (FDE) Research Assistant Senior Scientist - Receptor Pharmacology
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc Switzerland, November 15, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical pioneering allosteric modulation-based drug discovery and development, today announced that Janssen Pharmaceuticals , Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Pharmacology isn’t only about ligands, receptors, and downstream G protein signaling—it’s also about Clarify whether observed effects reflect true pharmacology or assay artifacts . From Bench Insight to Strategic Advantage Terry Kenakin’s decades of pharmacology leadership converge Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full A growing on-demand library of expert pharmacology lessons to revisit anytime.



























